Meaning-Centered Psychotherapy in Advanced Cancer

Back to results

Primary Purpose

Status

Completed

Phase

Phase 2

Locations

United States

Study Type

Interventional

Intervention

Meaning-Centered Group Psychotherapy

Standard Supportive Group Psychotherapy

About this trial

This is an interventional educational/counseling/training trial for Lymphoma, Non-Hodgkin focused on measuring Stage 3 cancer;, Stage 4 cancer;, solid tumor cancer;, Non-Hodgkin's Lymphoma;, solid tumors;, end-stage cancer;, group psychotherapy;, psychotherapy;, emotional support;, support groups

Eligibility Criteria

21 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria: 21 years of age or older; English speaking; Stage III or IV solid-tumor or Non-Hodgkin's Lymphoma; Receiving ambulatory care at Memorial Sloan-Kettering Cancer Center in New York City; Exclusion Criteria: Significant psychiatric disturbance sufficient, in the investigator's judgment, to preclude participation in a group-format intervention; Presence of cognitive impairment disorder, such as delirium or dementia that is sufficient, in the investigator's opinion, to preclude meaningful participation and/or informed consent; Karnofsky Performance Rating Scale below 50 or physical limitations or illness severity sufficient to preclude participation in outpatient group psychotherapy.

Sites / Locations

Memorial Sloan-Kettering Institute for Cancer Research

Outcomes

Primary Outcome Measures

Secondary Outcome Measures

Full Information

NCT ID

NCT00067288

First Posted

August 14, 2003

Last Updated

August 16, 2006

Sponsor

National Center for Complementary and Integrative Health (NCCIH)

1. Study Identification

Unique Protocol Identification Number

NCT00067288

Brief Title

Meaning-Centered Psychotherapy in Advanced Cancer

Official Title

Meaning-Centered Psychotherapy in Advanced Cancer

Study Type

Interventional

2. Study Status

Record Verification Date

August 2006

Overall Recruitment Status

Completed

Study Start Date

May 2002 (undefined)

Primary Completion Date

undefined (undefined)

Study Completion Date

March 2006 (undefined)

3. Sponsor/Collaborators

Name of the Sponsor

National Center for Complementary and Integrative Health (NCCIH)

4. Oversight

5. Study Description

Brief Summary

We have developed an 8-week Meaning-Centered Group Psychotherapy designed to help patients with advanced cancer sustain or enhance a sense of meaning, peace and purpose despite the limitations of their cancer illness. This project's overall aim is to explore the feasibility and efficacy of this new and unique psychotherapy intervention for advanced cancer patients in enhancing psychological and spiritual well-being and quality of life by comparing it with a standard supportive group psychotherapy.

Detailed Description

As per Brief Summary

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study

Lymphoma, Non-Hodgkin, Neoplasms

Keywords

Stage 3 cancer;, Stage 4 cancer;, solid tumor cancer;, Non-Hodgkin's Lymphoma;, solid tumors;, end-stage cancer;, group psychotherapy;, psychotherapy;, emotional support;, support groups

7. Study Design

Primary Purpose

Educational/Counseling/Training

Study Phase

Phase 2

Interventional Study Model

Single Group Assignment

Masking

None (Open Label)

Allocation

Randomized

Enrollment

118 (false)

8. Arms, Groups, and Interventions

Intervention Type

Behavioral

Intervention Name(s)

Meaning-Centered Group Psychotherapy

Intervention Type

Behavioral

Intervention Name(s)

Standard Supportive Group Psychotherapy

10. Eligibility

Sex

All

Minimum Age & Unit of Time

21 Years

Accepts Healthy Volunteers

No

Eligibility Criteria

Inclusion Criteria: 21 years of age or older; English speaking; Stage III or IV solid-tumor or Non-Hodgkin's Lymphoma; Receiving ambulatory care at Memorial Sloan-Kettering Cancer Center in New York City; Exclusion Criteria: Significant psychiatric disturbance sufficient, in the investigator's judgment, to preclude participation in a group-format intervention; Presence of cognitive impairment disorder, such as delirium or dementia that is sufficient, in the investigator's opinion, to preclude meaningful participation and/or informed consent; Karnofsky Performance Rating Scale below 50 or physical limitations or illness severity sufficient to preclude participation in outpatient group psychotherapy.

Overall Study Officials:

First Name & Middle Initial & Last Name & Degree

William Breitbart, MD

Organizational Affiliation

Memorial Sloan Kettering Cancer Center

Official's Role

Principal Investigator

First Name & Middle Initial & Last Name & Degree

Christopher Gibson, PhD

Organizational Affiliation

Project Coordinator Memorial Sloan-Kettering Cancer Center

Facility Information:

Facility Name

Memorial Sloan-Kettering Institute for Cancer Research

City

New York

State/Province

New York

ZIP/Postal Code

10021

Country

United States

Lymphoma, Non-Hodgkin, Neoplasms

About this trial

Eligibility Criteria

Sites / Locations

Outcomes

Primary Outcome Measures

Secondary Outcome Measures

Full Information

1. Study Identification

2. Study Status

3. Sponsor/Collaborators

4. Oversight

5. Study Description

6. Conditions and Keywords

7. Study Design

8. Arms, Groups, and Interventions

10. Eligibility

12. IPD Sharing Statement

Learn more about this trial